Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HIV broadly neutralizing antibodies with enhanced Fc-CD16 affinity increase NK cell ADCC even with limited envelope binding.

bioRxiv : the preprint server for biology·2026
Same author

Loss of Vpr-driven TRAIL-R2 expression protects HIV-infected cells from non-canonical NK cell TRAIL attack.

bioRxiv : the preprint server for biology·2026
Same author

Clonal dynamics of HIV-infected and uninfected T cells.

EBioMedicine·2026
Same author

γc-cytokines in HIV Cure Research.

Current opinion in HIV and AIDS·2026
Same author

Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer.

Nature biomedical engineering·2026
Same author

Structures of nucleotide-bound Redondovirus Rep protein link conformation and function.

PLoS pathogens·2026

Related Experiment Video

Updated: May 8, 2026

CRISPR-Cas9-based Genome Engineering to Generate Jurkat Reporter Models for HIV-1 Infection with Selected Proviral Integration Sites
14:27

CRISPR-Cas9-based Genome Engineering to Generate Jurkat Reporter Models for HIV-1 Infection with Selected Proviral Integration Sites

Published on: November 14, 2018

HIV latency and integration site placement in five cell-based models.

Scott Sherrill-Mix1, Mary K Lewinski, Marylinda Famiglietti

  • 1Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. shescott@mail.med.upenn.edu

Retrovirology
|August 20, 2013
PubMed
Summary

Understanding human immunodeficiency virus (HIV) latency is key to eradication. This study found that while chromosomal position influences HIV latency, the exact molecular mechanisms may vary across different in vitro models.

More Related Videos

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites
09:31

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites

Published on: March 22, 2016

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

Related Experiment Videos

Last Updated: May 8, 2026

CRISPR-Cas9-based Genome Engineering to Generate Jurkat Reporter Models for HIV-1 Infection with Selected Proviral Integration Sites
14:27

CRISPR-Cas9-based Genome Engineering to Generate Jurkat Reporter Models for HIV-1 Infection with Selected Proviral Integration Sites

Published on: November 14, 2018

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites
09:31

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites

Published on: March 22, 2016

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

Area of Science:

  • Virology
  • Immunology
  • Genomics

Background:

  • Antiretroviral therapy effectively manages human immunodeficiency virus (HIV) infection.
  • Persistent latent reservoirs of integrated proviruses prevent HIV eradication.
  • The influence of chromosomal environment on HIV latency is known, but mechanisms remain unclear.

Purpose of the Study:

  • To investigate the determinants of HIV latency.
  • To compare latency mechanisms across different in vitro models.
  • To clarify the role of the chromosomal environment in HIV transcriptional repression.

Main Methods:

  • Comparison of five in vitro models of HIV latency using primary human T cells and a T cell line.
  • In vitro infection, separation of expressed and silent/inducible proviruses.
  • Sequencing of integration site populations and analysis of genomic annotations.

Main Results:

  • Analysis of 6,252 expressed and 6,184 silent/inducible proviruses revealed no consistent predictors of latency across models.
  • Genomic features showed significant associations with proviral expression in individual models.
  • Proviruses in the same chromosomal region shared status within a model but not across different models.

Conclusions:

  • The silent/inducible phenotype of HIV proviruses is linked to chromosomal position.
  • The precise molecular basis of this association is not fully elucidated.
  • Mechanisms driving HIV latency may differ across various in vitro models.